Phase 3 trial of Novavax investigational COVID-19 vaccine opens
National Institutes of Health (NIH) sent this bulletin at 12/28/2020 09:30 AM ESTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
12/28/2020 09:15 AM EST
NIH- and BARDA-funded trial will enroll up to 30,000 volunteers.